Xenetic Biosciences, Inc. (XBIO)
USD 4.06
(3.05%)
USD 4.06
(3.05%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 2.53 Million | 1.7 Million | 1.16 Million | 436.94 Thousand | 17.06 Thousand | - |
| Cost of Revenue | - | 27.04 Thousand | 35.48 Thousand | - | - | 15.82 Thousand |
| Gross Profit | 2.53 Million | 1.67 Million | 1.12 Million | 436.94 Thousand | 17.06 Thousand | -15.82 Thousand |
| Operating Expenses | 7.05 Million | 8.42 Million | 6.9 Million | 5.13 Million | 9.62 Million | 7.27 Million |
| Selling, General and Administrative Expenses | 3.56 Million | 3.65 Million | 3.74 Million | 3.4 Million | 4.73 Million | 4.39 Million |
| Research and Development Expenses | 3.49 Million | 4.77 Million | 3.16 Million | 1.73 Million | 4.88 Million | 2.88 Million |
| Other Expenses | - | -1597.00 | 1119.00 | -492.00 | 3315.00 | -24.64 Thousand |
| Cost and Expenses | 7.05 Million | 8.42 Million | 6.9 Million | 5.13 Million | 9.62 Million | 7.27 Million |
| Operating Income | -4.51 Million | -6.71 Million | -5.74 Million | 4.54 Million | -12.88 Million | -7.27 Million |
| Interest Expense | - | - | - | - | - | 24.13 Thousand |
| Income Tax Expense | - | -165.55 Thousand | -100.46 Thousand | -2.91 Million | 3.17 Million | 24.13 Thousand |
| Earnings before Tax | -4.13 Million | -6.55 Million | -5.64 Million | -13.81 Million | -12.77 Million | -7.3 Million |
| Net Income | -4.13 Million | -6.38 Million | -5.54 Million | -10.89 Million | -15.94 Million | -7.3 Million |
| Earnings Per Share Basic | -2.71 | -4.49 | -5.39 | -17.04 | -55.92 | -96.58 |
| Earnings Per Share Diluted | -2.71 | -4.49 | -5.39 | -17.04 | -55.92 | -96.57 |
| Weighted Average Shares Outstanding | 1.52 Million | 1.42 Million | 1.02 Million | 639.23 Thousand | 285.24 Thousand | 75.59 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 1.52 Million | 1.42 Million | 1.02 Million | 639.23 Thousand | 285.24 Thousand | 75.6 Thousand |
| Gross Margin | 1.00 | 0.98 | 0.97 | 1.00 | 1.00 | - |
| EBIT Margin | -1.78 | -3.92 | -4.92 | 10.48 | -368.72 | - |
| Profit Margin | -1.63 | -3.74 | -4.78 | -24.93 | -934.60 | - |
| EBITDA | -4.51 Million | -6.71 Million | -5.71 Million | -4.69 Million | -9.57 Million | -7.26 Million |
| Earnings Before Tax Margin | -1.78 | -3.94 | -4.95 | 10.41 | -755.12 | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 726.4 Thousand | 510.81 Thousand | 2.53 Million | 671.96 Thousand | 611.17 Thousand | 651 Thousand |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | 726.4 Thousand | 510.81 Thousand | 2.53 Million | 671.96 Thousand | 611.17 Thousand | 651 Thousand |
| Operating Expenses | 2.06 Million | 1.77 Million | 7.05 Million | 1.92 Million | 1.75 Million | 1.84 Million |
| Selling, General and Administrative Expenses | 1.13 Million | 834.91 Thousand | - | 952 Thousand | 737.24 Thousand | 945.95 Thousand |
| Research and Development Expenses | 933.77 Thousand | 944.32 Thousand | - | 975.62 Thousand | 1.02 Million | 903.24 Thousand |
| Other Expenses | -21.00 | 52.00 | 25.38 Thousand | 404.00 | -666.00 | 21.12 Thousand |
| Cost and Expenses | 2.06 Million | 1.77 Million | 7.05 Million | 1.92 Million | 1.75 Million | 1.84 Million |
| Operating Income | -1.33 Million | -1.26 Million | -4.51 Million | -1.25 Million | -1.14 Million | -1.19 Million |
| Interest Expense | - | - | - | 58.62 Thousand | - | - |
| Income Tax Expense | -18.98 Thousand | 10.62 Thousand | 28.2 Thousand | 7849.00 | -99.43 Thousand | -128.96 Thousand |
| Earnings before Tax | -1.27 Million | -1.19 Million | -4.13 Million | -1.17 Million | -1.05 Million | -1.05 Million |
| Net Income | -1.27 Million | -1.19 Million | -4.13 Million | -1.17 Million | -1.05 Million | -1.05 Million |
| Earnings Per Share Basic | -0.83 | -0.78 | - | -0.76 | -0.69 | -0.69 |
| Earnings Per Share Diluted | -0.83 | -0.78 | - | -0.76 | -0.69 | -0.69 |
| Weighted Average Shares Outstanding | 1.54 Million | 1.54 Million | 1.52 Million | 1.53 Million | 1.53 Million | 1.52 Million |
| Weighted Average Shares Outstanding (Diluted) | 1.54 Million | 1.54 Million | 1.52 Million | 1.53 Million | 1.53 Million | 1.52 Million |
| Gross Margin | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| EBIT Margin | -1.84 | -2.48 | - | -1.87 | -1.88 | -1.84 |
| Profit Margin | -1.75 | -2.34 | -1.63 | -1.74 | -1.73 | -1.61 |
| EBITDA | -1.33 Million | -1.26 Million | - | -1.25 Million | -1.14 Million | -1.19 Million |
| Earnings Before Tax Margin | -1.84 | -2.48 | -1.78 | -1.87 | -1.88 | -1.84 |
CABJF
SMIT
SIFY
2728
C1X
ADANIPORTS